ASH 2020: MDS

Advertisement
DocWire News EditorsASH Annual Meeting 2020 | August 30, 2023
Hypomethylating agents (HMAs) are the current standard of care in patients with high-risk myelodysplastic ...
Read More
DocWire News EditorsASH Annual Meeting 2020 | August 30, 2023
Many patients with myelodysplastic syndromes (MDS) are dependent on blood transfusions. Therefore, sufficient blood ...
DocWire News EditorsASH Annual Meeting 2020 | August 30, 2023
Patients with cancer often face financial toxicity due to the effects of disease on the ability to work, as well as the ...
DocWire News EditorsASH Annual Meeting 2020 | August 24, 2023
The Revised International Prognostic Scoring System (IPSS-R) is a useful tool to predict clinical outcomes in patients ...
DocWire News EditorsASH Annual Meeting 2020 | August 24, 2023
The Revised International Prognostic Scoring System (IPSS-R) is the standard tool to predict prognosis for patients with ...
DocWire News EditorsASH Annual Meeting 2020 | August 24, 2023
Research presented at the 62nd ASH Annual Meeting & Exposition indicates that the presence of cardiovascular disease ...
DocWire News EditorsASH Annual Meeting 2020 | August 24, 2023
Histological and cytomorphological examinations are vital to diagnosis of myelodysplastic syndromes (MDS). But accurate ...
DocWire News EditorsASH Annual Meeting 2020 | August 24, 2023
According to research presented at the 62nd ASH Annual Meeting & Exposition, combining pathology reviews with ...
DocWire News EditorsASH Annual Meeting 2020 | August 30, 2023
A longitudinal research study out of an Austrian institute identified several disease-specific and patient-related ...
DocWire News EditorsASH Annual Meeting 2020 | August 30, 2023
Studies have found that combining patient-reported outcomes (PROs) with more traditional disease classification systems, ...
DocWire News EditorsASH Annual Meeting 2020 | August 30, 2023
Iron overload is linked to higher rates of complications and mortality in patients with myelodysplastic syndromes (MDS). ...
DocWire News EditorsASH Annual Meeting 2020 | August 30, 2023
Iron overload has been identified as a common and important issue in the management of patients with myelodysplastic ...
DocWire News EditorsASH Annual Meeting 2020 | August 30, 2023
A mounting body of evidence shows that gender plays an essential role in many facets of myriad diseases, such as risk ...
DocWire News EditorsASH Annual Meeting 2020 | August 30, 2023
A study presented at the 62nd ASH Annual Meeting & Exposition demonstrated that allogeneic hematopoietic cell ...
DocWire News EditorsASH Annual Meeting 2020 | August 30, 2023
A study presented at the 62nd ASH Annual Meeting & Exposition found that patients with myelodysplastic syndromes ...
DocWire News EditorsASH Annual Meeting 2020 | August 30, 2023
Scientists are just beginning to explore the effects of COVID-19 (SARS-CoV-2) on specific populations of patients with ...
Advertisement
Advertisement
Advertisement
Latest News

March 14, 2025